Alrex and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Alrex (loteprednol etabonate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Crohn's disease.

The phase IV clinical study analyzes which people have Rashes when taking Alrex. It is created by eHealthMe based on reports of 652 people who have side effects when taking Alrex from the FDA, and is updated regularly.

What is Alrex?

Alrex has active ingredients of loteprednol etabonate. eHealthMe is studying from 663 Alrex users. Check the latest studies of Alrex.

What is Rashes?

Rashes (redness) is found to be associated with 3,715 drugs and 6,215 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

652 people reported to have side effects when taking Alrex.
Among them, 21 people (3.22%) have Rashes.

Among these 21 people:

How long have people been on Alrex when they have Rashes? *

What is the gender of people who have Rashes when taking Alrex? *

female: 85 %
male: 15 %

What is the age of people who have Rashes when taking Alrex? *

What are other drugs people take besides Alrex? *

What are other side effects people have besides Rashes? *

Pain: 5 people, 23.81%
Headache (pain in head): 4 people, 19.05%
Eye Irritation: 4 people, 19.05%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 14.29%
Itching: 3 people, 14.29%
Drug Ineffective: 3 people, 14.29%
Eye Infection: 3 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 14.29%
Fever: 3 people, 14.29%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 9.52%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Dry Eyes (lack of adequate tears): 2 people, 9.52%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 9.52%
Allergies: 2 people, 9.52%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 9.52%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.76%
Asthma: 1 person, 4.76%
Back Pain: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Alrex and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alrex:

Alrex (663 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Alrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,215 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loteprednol etabonate (the active ingredients of Alrex) and Alrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.